Sexual Health Assessment
The 5Ps Sexual History Framework
A structured, comprehensive approach to taking a sensitive sexual history. Use open, non-judgmental language throughout.
P1
PartnersHow many partners in the last 3/12 months? Gender of partners? Regular vs. casual? Has the partner been tested?
P2
PracticesType of sexual activity (vaginal, anal, oral)? Insertive or receptive roles? Site-specific screening guided by practice.
P3
Protection from STIsCondom use — consistent, inconsistent, never? Barriers used for oral/anal sex? Reason for inconsistent use?
P4
Past STI HistoryPrevious STIs? When diagnosed? Treated? Partner(s) notified and treated? HIV/hepatitis B/C status known?
P5
Pregnancy IntentionContraception currently used? Planning pregnancy? Last menstrual period? Relevant to treatment choices.
Creating a Safe Environment
- Ensure visual and auditory privacy — closed door, no interruptions
- Offer single-gender staff if clinically appropriate and feasible
- Introduce yourself and explain confidentiality limits clearly at the start
- Use professional interpreters (never family members) for language barriers
- Sit at the same level — avoid standing above the patient
- Use normalising statements: "I ask everyone these questions routinely"
- Allow pauses; do not rush sensitive disclosures
- Document that a sexual history was taken without recording identifying details unnecessarily
Non-Judgmental Communication
Language Principles
- Use gender-neutral language initially: "partners" not "boyfriend/wife"
- Avoid assumptions about relationship structures or sexual orientation
- Use person-first language: "person living with HIV" not "HIV patient"
- Avoid loaded terms: use "sex" not "intercourse" exclusively; "unprotected sex" not "risky behaviour"
Verbal Cues to Avoid
- Raised intonation suggesting surprise
- Expressions of moral judgement ("you should have...")
- Prolonged silence after a disclosure
- Rushing to reassurance before listening fully
Documentation & Confidentiality in GCC
Confidentiality Principles
- Sexual health information is highly sensitive — limit access to treating team only
- Do not document in shared family notes (common in family medicine settings)
- Electronic records: ensure sexual history fields are access-restricted
- HIV and STI status should not appear on employer medical certificates without consent
- Employer medical reports: disclose only what is legally required
GCC-Specific Legal Considerations
Mandatory Reporting: Some GCC jurisdictions require notification of HIV, syphilis, gonorrhoea, and hepatitis B to public health authorities. Know local requirements for your country of practice.
Immigration Link: HIV-positive status typically leads to deportation for expatriates in most GCC states. Patients may under-disclose due to this fear — build trust explicitly.
Residency Visas: Mandatory blood screening for HIV/hepatitis/TB on visa renewal. Nurses facilitate this process — maintain non-judgmental approach.
LGBTQ+ Considerations in Restrictive Legal Environments
Legal Context: Same-sex sexual activity is criminalised across all GCC countries. Penalties vary from fines to imprisonment. This creates unique barriers to sexual health care access.
Clinical Obligations Remain Unchanged
- Every patient has the right to dignified, non-discriminatory care regardless of sexual orientation
- Never refuse care or alter quality of care based on disclosed identity or practices
- Do not disclose sexual orientation or practices to authorities without patient consent (unless legally compelled)
- Screen appropriately for the sexual practices disclosed — MSM require pharyngeal/rectal swabs
- HIV and STI risk counselling must address actual practices, not assumed heterosexual norms
Practice Guidance
- Many LGBTQ+ individuals will not disclose in GCC — use open, non-assuming questions
- "Do you have sex with men, women, or both?" normalises disclosure
- If a patient discloses, do not record sexual orientation in employer-accessible notes
- Refer to mental health support — higher rates of anxiety/depression in criminalised environments
- Know your facility's policy on mandatory reporting — seek senior clinical guidance
Ethical Principle: Clinical confidentiality and patient welfare take precedence. Seek legal and ethical guidance from your regulatory body if unsure.
Cultural Sensitivity in GCC Sexual Health
Modesty & Privacy
- Many patients (especially women) are accompanied — request private consultation sensitively
- Same-gender clinicians preferred for intimate examinations
- Allow patients to maintain covering during examination where clinically safe
Family & Community Dynamics
- Family honour may be a significant concern — address confidentiality early
- Never discuss patient's sexual health with family without explicit consent
- Acknowledge cultural context without making assumptions about individual beliefs
Premarital Sex Taboo
- Patients may not disclose sexual activity if unmarried — use non-assuming questions
- "Are you sexually active?" — if denied, note this; offer re-consultation
- STI presentations may be explained by patients as "infection" — explore gently
STI Nursing Management
Common STI Treatment Reference
| STI | First-Line Treatment | Alternative | Notes for GCC Nurses |
|---|---|---|---|
| Chlamydia | Doxycycline 100mg BD × 7 days | Azithromycin 1g stat (if compliance concern) | Doxycycline preferred for treatment efficacy; avoid in pregnancy — use azithromycin |
| Gonorrhoea | Ceftriaxone 1g IM stat (dual therapy with azithromycin 2g if resistance suspected) | Local sensitivity-guided therapy | Increasing fluoroquinolone/cephalosporin resistance in GCC — always culture before treatment when possible |
| Syphilis (primary/secondary) | Benzathine penicillin G 2.4 MU IM single dose | Doxycycline 100mg BD × 14 days (penicillin allergy) | Assess Jarisch-Herxheimer reaction risk — monitor 4–6 hours post-injection |
| Syphilis (latent/tertiary) | Benzathine penicillin G 2.4 MU IM weekly × 3 doses | Doxycycline 100mg BD × 28 days | Neurosyphilis requires IV penicillin — refer to specialist |
| Genital Herpes (HSV) | Aciclovir 400mg TDS × 5 days (episodic) | Valaciclovir 500mg BD × 5 days | Suppressive: aciclovir 400mg BD long-term reduces transmission and recurrence frequency |
| Genital Warts (HPV) | Imiquimod 5% cream / Podophyllotoxin 0.5% | Cryotherapy, electrocautery | HPV types 16/18 — cervical screening link; encourage vaccination (available in UAE, Qatar, KSA) |
| PID | Ceftriaxone 500mg IM stat + Doxycycline 100mg BD × 14d + Metronidazole 400mg BD × 14d | Ofloxacin-based regimen if penicillin allergy | Inpatient if severe, pregnant, or surgical emergency suspected |
| Trichomonas | Metronidazole 2g stat | Metronidazole 400mg BD × 5–7 days | Treat partners simultaneously; avoid alcohol during treatment |
Syphilis Staging Guide
Primary (10–90 days post-exposure)
- Painless indurated genital ulcer (chancre)
- Inguinal lymphadenopathy
- Spontaneously resolves — do not reassure without treatment
Secondary (6 weeks–6 months)
- Non-itchy copper-coloured palmar/plantar rash — pathognomonic
- Condylomata lata (flat warts), mucous patches
- Systemic symptoms: fever, lymphadenopathy, malaise
Latent (asymptomatic)
- Early latent: <2 years; Late latent: >2 years
- Detectable only by serology (VDRL/TPHA)
Tertiary (>3–10 years untreated)
- Gummas, cardiovascular syphilis (aortitis), neurosyphilis
- Refer immediately to specialist
Gonorrhoea & Antimicrobial Resistance
Critical: Neisseria gonorrhoeae resistance to fluoroquinolones is now widespread in GCC. Cephalosporin resistance is emerging. Always send culture and sensitivity before empirical treatment.
Nursing Actions for Suspected Gonorrhoea
- Collect urethral/endocervical swab for NAAT and culture before antibiotics
- Pharyngeal and rectal swabs if practices indicate
- Administer ceftriaxone IM as single dose — ensure patient waits 30 min (anaphylaxis risk)
- Advise no sexual contact for 7 days after treatment AND until partner treated
- Test-of-cure recommended 2 weeks post-treatment for pharyngeal infection
- Report to public health authority per local law
Ophthalmia Neonatorum
Gonorrhoeal eye infection in newborns is a medical emergency — prophylactic erythromycin eye drops at birth; immediate ophthalmology referral if signs develop
Contact Tracing & Partner Notification in GCC Context
Standard Contact Tracing Periods
| STI | Look-Back Period |
|---|---|
| Chlamydia | 6 months or last partner |
| Gonorrhoea | 3 months or last partner |
| Syphilis (primary) | 3 months + 10 days |
| Syphilis (secondary) | 6 months + 10 days |
| HIV | 3–6 months pre-diagnosis |
Notification Methods
- Patient referral: Patient informs partner(s) directly — preferred in GCC
- Provider referral: Clinic contacts partner — used only with consent
- Expedited partner therapy (EPT): Limited availability in GCC — requires prescriber involvement
GCC Legal Considerations
Disclosure Risk: Revealing an STI to a partner may inadvertently expose the patient's sexual behaviour or status — particularly relevant for unmarried individuals or those with multiple partners in restrictive legal environments.
Legal Coercion Concerns: Mandatory partner notification for HIV exists in some GCC states. Understand local legislation (UAE Federal Law No. 14/2008 on Communicable Diseases; Saudi MOH guidelines).
Nursing Role in Partner Notification
- Counsel patients on importance of partner notification for their health
- Document the patient's decision and counselling provided
- Provide written materials patients can share with partners
- Never contact partner without explicit patient consent (unless legally required)
HIV in GCC
HIV Transmission & Prevention
Routes of Transmission
- Unprotected sexual intercourse (vaginal, anal — anal highest risk)
- Sharing contaminated needles/syringes (PWID)
- Mother-to-child (vertical) — during pregnancy, delivery, breastfeeding
- Contaminated blood products (rare in GCC with screening)
- Occupational needlestick/sharps injury
Prevention Education Points
- Consistent correct condom use reduces transmission by ~80–95%
- Treatment as Prevention (TasP): undetectable = untransmittable (U=U)
- PMTCT programmes: ART in pregnancy reduces vertical transmission to <1%
- Harm reduction counselling for PWID (needle exchange limited in GCC)
- Discuss PrEP where legally available
ART Overview & Adherence Support
HAART Overview for Nurses
Highly Active Antiretroviral Therapy typically involves 2 NRTIs + 1 third agent. Modern single-tablet regimens (STRs) improve adherence.
| Class | Examples |
|---|---|
| NRTIs (backbone) | Tenofovir (TDF/TAF), Emtricitabine, Abacavir |
| NNRTIs | Efavirenz, Rilpivirine, Doravirine |
| Integrase Inhibitors (preferred) | Dolutegravir, Bictegravir, Raltegravir |
| Protease Inhibitors | Darunavir/ritonavir, Lopinavir/ritonavir |
Adherence Support Nursing Role
- Educate: >95% adherence required to maintain viral suppression
- Use pill organiser, phone alarms, medication diary
- Address side effects proactively (nausea, fatigue, lipodystrophy)
- Explore psychosocial barriers: stigma, depression, disclosure fears
- Never abruptly stop ART — risk of resistance and rebound
HIV Testing in GCC — Mandatory Screening
Mandatory Testing Contexts
Residency/Work Visa: All expatriate workers require HIV testing on entry and renewal in all GCC states. HIV-positive result results in visa denial/deportation — counsel patients before testing.
- Pre-employment medical: UAE, KSA, Qatar, Kuwait, Bahrain, Oman
- Antenatal testing: routine in all GCC ANC programmes
- Blood donation screening: mandatory, universal
- Pre-marital health certificate: includes HIV in KSA, UAE, Qatar
- Some countries: prison entry screening
Voluntary Confidential Testing
- Pre-test counselling: explain procedure, window period, implications
- 4th generation Ag/Ab combo test: detects from 18–45 days post-exposure
- Window period: 45 days with 4th gen; 3 months for definitive negative
- Repeat testing: if high-risk exposure within window period
- Post-test counselling: both reactive and non-reactive results require support
GCC Disclosure & Legal Risk
Expatriates face deportation on HIV diagnosis. GCC nationals may face family and community stigma. Counselling before any HIV test in GCC must explicitly address these risks and implications.
CD4 & Viral Load Monitoring
| Test | Frequency | Nursing Role |
|---|---|---|
| CD4 count | At baseline, then 3–6 monthly until stable; annually if suppressed | Explain values: normal >500; <200 = AIDS-defining; support psychological response |
| Viral load (VL) | At baseline, 1 month after ART start, then 3–6 monthly; aim <50 copies/mL | Undetectable VL = untransmittable (U=U) — reinforce positive message for adherence |
| Resistance testing | Pre-ART baseline and on treatment failure | Ensure sample reaches lab as genotyping is specialist test |
| Routine bloods | FBC, LFTs, U&Es, lipids, glucose, HbA1c — 6 monthly | Monitor for ART side effects: renal toxicity (TDF), metabolic changes |
PEP — Post-Exposure Prophylaxis
Time-Critical: Must start within 72 hours of exposure. Earlier = more effective. Do not delay.
PEP Indications
- Occupational: needlestick/sharps injury with known/suspected HIV-positive source
- Non-occupational: unprotected sex with HIV-positive or high-risk unknown status partner
- Sexual assault
Standard PEP Regimen (28 days)
- Tenofovir/Emtricitabine (TDF/FTC) 300/200mg once daily
- + Raltegravir 400mg twice daily (or dolutegravir)
- Baseline HIV test, renal function, FBC at start
- HIV test at 6 weeks (Ag/Ab) and 3 months
PrEP in GCC Context
PrEP (pre-exposure prophylaxis with TDF/FTC) is not routinely available or approved in most GCC states as of 2024. Nurses should be aware of its existence and refer expatriates to home country services or specialist HIV clinics where available.
HIV Stigma Management in GCC
Sources of Stigma in GCC Context
- Association of HIV with illegal sexual behaviour or drug use
- Religious and cultural judgements
- Workplace discrimination and risk of job loss
- Immigration consequences
- Family and community shame/dishonour
Nursing Interventions
- Use non-stigmatising language consistently — "person living with HIV (PLHIV)"
- Educate on modern ART outcomes: HIV is a chronic manageable condition
- Reinforce U=U to reduce fear of transmission and encourage disclosure
- Connect with peer support networks where available
- Assess and address depression, anxiety, suicidal ideation — common in PLHIV post-diagnosis
- Advocate for the patient within healthcare system for dignified, equal care
Contraception Nursing
Contraceptive Methods Overview
| Method | Typical Use Failure Rate | Duration | Key Points for GCC Nurses |
|---|---|---|---|
| Combined Oral Pill (COCP) | 7–9% | Daily | Numerous health benefits; avoid if migraine with aura, VTE history, smoker >35yrs, hypertension |
| Progestogen-Only Pill (POP) | 7–9% | Daily — must take within 3-hour window (traditional) | Suitable where oestrogen contraindicated; desogestrel POP has 12-hour window |
| Implant (Nexplanon) | <0.1% | 3 years | LARC — most effective method; inserted subdermally upper arm; counselling on irregular bleeding |
| IUD — Copper (non-hormonal) | <1% | 5–10 years | Halal option — no hormones; also used as emergency contraception within 5 days; heavier periods |
| IUS (Mirena) | <0.2% | 5–8 years | Reduces heavy menstrual bleeding; local progestogen effect; suitable for most women |
| Depot Medroxyprogesterone (DMPA) | 4–6% | 12–13 weeks | Discuss bone density; return of fertility may be delayed up to 1 year |
| Male Condoms | 13–15% | Per use | Only method that protects against STIs; dual protection counselling; available in GCC pharmacies |
| Female Condoms | 21% | Per use | Female-controlled STI protection; limited availability in GCC |
Islamic Perspective on Family Planning
Scholarly Consensus: The majority of Islamic scholars permit contraception for family planning purposes. The fatwa of most GCC-based religious authorities supports the use of contraception within marriage for valid reasons (health, financial, timing between pregnancies).
Key Points for Counselling
- Contraception is generally permitted (mubah) within marriage in Sunni jurisprudence
- Permanent methods (vasectomy/tubal ligation) are more contested — counselling needed; many scholars permit if childbearing is complete
- Contraception outside of marriage is a separate legal/ethical matter — focus on clinical care without judgement
- Copper IUD is preferred by some patients as a "natural", hormone-free, halal option
- Sensitive to patient's own religious interpretation — do not impose one view; provide information and support patient choice
Emergency Contraception
| Method | Window | Efficacy |
|---|---|---|
| Levonorgestrel (LNG) 1.5mg | Up to 72 hours (less effective 72–120h) | ~85% if taken promptly |
| Ulipristal acetate (UPA) | Up to 120 hours | Higher efficacy than LNG at 72–120h |
| Copper IUD | Up to 120 hours (5 days) | >99% — most effective |
GCC Context: Emergency contraception (EC) is available in GCC pharmacies. In most GCC countries it is sold without prescription. Nurses should counsel about EC as a method for unprotected sex, NOT as an abortion — it prevents implantation. EC does not terminate an established pregnancy.
Counselling Points
- Does not cause abortion — acts before implantation
- Explain importance of taking LNG ASAP — efficacy decreases with time
- Copper IUD can double as ongoing long-term contraception
- Follow up for regular contraception after EC use
UKMEC Eligibility Criteria — Key Contraindications Reference
UKMEC categories: Cat 1 No restriction Cat 2 Benefits outweigh risks Cat 3 Risks outweigh benefits Cat 4 Unacceptable risk
| Condition | COCP | POP | Implant | IUD (Cu) | IUS |
|---|---|---|---|---|---|
| Migraine with aura | Cat 4 | Cat 2 | Cat 2 | Cat 1 | Cat 2 |
| Hypertension (>160/100) | Cat 4 | Cat 2 | Cat 2 | Cat 1 | Cat 2 |
| Smoker >35 yrs (>15/day) | Cat 4 | Cat 2 | Cat 2 | Cat 1 | Cat 1 |
| Diabetes with complications | Cat 3/4 | Cat 2 | Cat 2 | Cat 1 | Cat 2 |
| Breastfeeding (<6 weeks PP) | Cat 4 | Cat 3 | Cat 3 | Cat 2 | Cat 3 |
| Breastfeeding (>6 weeks PP) | Cat 3 | Cat 1 | Cat 1 | Cat 1 | Cat 1 |
| Active liver disease | Cat 4 | Cat 3 | Cat 3 | Cat 1 | Cat 3 |
| History of VTE | Cat 4 | Cat 2 | Cat 2 | Cat 1 | Cat 2 |
Interactive Contraceptive Method Selector
Enter patient details to generate UKMEC-guided recommendations with counselling points
Method Recommendations
Personalised Counselling Points
Cervical & Reproductive Screening
Cervical Screening Programme
Cervical Cytology (Smear)
- Age to start: 25 years (UK/WHO guidance — varies by GCC country)
- Frequency: every 3 years (25–49), every 5 years (50–64)
- Technique: Liquid-based cytology (LBC) now standard; ectocervical and endocervical cells
- Inadequate samples: repeat within 3 months; 3 consecutive inadequate = colposcopy referral
Results & Actions
| Result | Action |
|---|---|
| Normal | Routine recall (3 or 5 years) |
| Borderline/Low-grade dyskaryosis | HPV testing; if HPV+, refer to colposcopy |
| High-grade dyskaryosis (CIN2/3) | Urgent colposcopy referral (2 weeks) |
| ?Invasive cancer | Same-day urgent referral |
Nurse Role in Colposcopy
- Pre-procedure counselling: explain procedure, expected sensations, duration
- Reassure: most CIN2/3 does not mean cancer
- Post-LLETZ/biopsy: vaginal discharge, spotting, avoid tampons/sex for 4 weeks
- Provide written follow-up information
HPV Vaccination in GCC
Availability: HPV vaccination programmes exist in UAE, Qatar, and Saudi Arabia. Coverage and schedules vary by emirate/region.
HPV Vaccine Details
- 9-valent Gardasil-9 (preferred): protects against HPV 6, 11, 16, 18, 31, 33, 45, 52, 58
- Types 16/18: cause ~70% of cervical cancers
- Types 6/11: cause ~90% of genital warts
- Ideally given before sexual debut; benefits extend to sexually active adults up to 45 years
- Schedule: 2 doses if given <15 years; 3 doses if ≥15 years or immunocompromised
Nursing Counselling Points
- Vaccine does NOT replace cervical screening — continue smear programme
- Vaccine does not treat existing HPV infection
- Culturally sensitive discussion: reassure families vaccine is for cancer prevention, not sexual activity promotion
- Boys should also be vaccinated — reduces HPV burden in community
Breast Self-Examination (BSE) Teaching
BSE Technique (5-Step AWARE Method)
- Aware: Know what is normal for you
- Wellness: Check regularly — ideally days 7–10 of menstrual cycle
- Any change: Look and feel for changes — in mirror and lying down
- Report: Report any changes to healthcare provider promptly
- Expert: Attend routine mammography as recommended
What to Look/Feel For
- New lump or thickening in breast or axilla
- Change in size, shape, or symmetry
- Skin changes: dimpling, puckering, redness, orange-peel texture
- Nipple changes: inversion, discharge (especially bloodstained)
- Pain in one area (new, persistent)
Mammography Screening in GCC
- UAE: Dubai Health Authority recommends annual mammogram from age 40; biennial 40–74 (DOH Abu Dhabi)
- Saudi Arabia: SCFHS/MOH guidelines — mammogram every 1–2 years from 40
- Qatar: PHCC national screening programme from age 40
- Many GCC women may present late — normalise screening in nursing education
Cultural Note: Breast examination can be culturally sensitive. Offer same-gender examiner; explain clinical necessity clearly; maintain dignity throughout. Some communities may have modesty concerns — address respectfully without dismissing.
BRCA Genetic Testing Counselling
- BRCA1/2 mutations: significantly increased lifetime risk of breast (50–85%) and ovarian cancer (15–40%)
- Criteria for referral: strong family history (multiple 1st/2nd-degree relatives with breast/ovarian cancer, young age at diagnosis, bilateral disease, male breast cancer)
- Ashkenazi Jewish, Middle Eastern, and South Asian populations may carry founder mutations — relevant for some GCC populations
Pre-test Counselling Points
- Explain what a positive vs negative result means (and implications for family members)
- Discuss surveillance options (MRI, mammography, CA-125) vs prophylactic surgery
- Psychological support: anxiety, family implications, insurance issues
- Results do not always give a clear answer — variants of uncertain significance
Menopause Nursing & HRT Counselling
Genitourinary Syndrome of Menopause (GSM)
- Affects ~50% of postmenopausal women; often under-reported due to embarrassment
- Symptoms: vaginal dryness, dyspareunia, urinary urgency/frequency, recurrent UTIs
- Local oestrogen (pessary/cream) highly effective — minimal systemic absorption
- Lubricants (non-hormonal) as adjunct — advise silicone-based for longevity
HRT Counselling Framework
- Benefits: vasomotor symptoms, GSM, bone protection, mood improvement
- Risks: small increased risk of VTE (oral) and breast cancer (combined HRT >5 years)
- Transdermal HRT has lower VTE risk than oral — preferred in higher-risk patients
- NICE (and international guidelines): risks generally outweighed by benefits in symptomatic women under 60 within 10 years of menopause
- Annual review: assess symptoms, risk factors, patient preference
GCC Practice: Discuss menopause openly — many GCC women find symptoms distressing but do not raise them due to cultural taboo around discussing gynaecological issues. Normalise the conversation.
GCC Cultural Context
Premarital Health Screening in GCC
Mandatory Premarital Screening
All GCC countries require premarital health certificates. Requirements vary by country.
| Country | Tests Included |
|---|---|
| Saudi Arabia | Sickle cell/thalassaemia, HIV, hepatitis B & C, syphilis, rubella (female) |
| UAE | Sickle cell/thalassaemia, HIV, hepatitis B & C, syphilis |
| Qatar | Haematological disorders, HIV, hepatitis B & C, syphilis, TB |
| Kuwait | Haematological, HIV, hepatitis B & C, syphilis, genetic counselling |
| Bahrain | Sickle cell/thalassaemia, HIV, hepatitis B & C, blood group |
| Oman | Sickle cell/thalassaemia, HIV, hepatitis, syphilis |
Nursing Role in Premarital Counselling
- Explain purpose of screening: disease prevention, informed reproductive decision-making
- Counsel compassionately on positive results before certificate is issued
- For sickle cell/thalassaemia both carrier: explain risk to offspring (25% affected), genetic counselling referral
- HIV/STI positive: full counselling, treatment referral, confidentiality assurance
- Certificate indicates "compatible" or "incompatible" (or risk level) — nurse should not interpret result without physician review
- Some couples may proceed regardless — continue supporting informed choice
Note: Mandatory reporting of HIV/hepatitis results to public health authorities is required in most GCC countries for premarital screening results.
Cultural Norms in GCC Sexual Health Practice
Modesty (Haya)
- Central Islamic value — applies to both genders
- Patients may use euphemisms for genitalia and sexual functions
- Offer written questionnaires for sensitive topics if verbal discussion is difficult
- Never examine beyond clinical necessity with appropriate chaperone
Privacy from Family
- Adult patients have absolute right to privacy from spouse, parents, in-laws
- Spouses do not have automatic right to know health information
- Some GCC cultural norms assume family involvement — politely but clearly explain patient's right to confidentiality
Male Authority Dynamics
- In some families, women may defer to husbands for health decisions
- Gently facilitate individual consultation — "I need to ask some personal questions"
- Never allow family members to speak for or make decisions on behalf of a competent adult
Same-Sex Couples — Clinical Care Without Judgment
Legal Reality: Homosexuality is illegal in all GCC countries. Penalties include fines, imprisonment, and deportation for expatriates. Despite this, LGBTQ+ individuals exist in all GCC societies and require healthcare.
The Nurse's Professional Duty
- Personal religious or cultural beliefs must not affect quality of care provided
- GCC nursing regulatory bodies (DHA, DOH, MOH, SCFHS, QCHP) all require non-discriminatory care
- If you cannot provide care without bias, you must facilitate transfer to another clinician — patient must not be left without care
- Do not disclose a patient's sexual orientation without consent (not a legally mandated disclosure in most GCC jurisdictions for orientation alone)
Clinical Considerations
- MSM: ensure pharyngeal and rectal STI screening is offered if practices disclosed
- Women who have sex with women: still require cervical screening; HPV transmission possible; bacterial vaginosis more common
- Trans individuals: hormone therapy interactions with medications; organ-based screening based on anatomy
- Mental health: significantly elevated rates of depression, anxiety, suicidal ideation in criminalised environments — screen and refer
Female Genital Cutting (FGC/FGM)
Prevalence Note: FGM/FGC is practised in some communities living in GCC, particularly from East African (Somalia, Ethiopia, Sudan, Eritrea), Egyptian, and some South/Southeast Asian backgrounds. It is not an Arab Gulf cultural practice but nurses will encounter affected patients.
WHO Classification
- Type I: Clitoridectomy (partial/total removal of clitoris)
- Type II: Excision (partial/total removal of clitoris + labia minora)
- Type III: Infibulation (narrowing of vaginal opening with seal)
- Type IV: All other harmful procedures (pricking, piercing, incising, scraping)
Nursing Response
- Document sensitively and accurately — never with derogatory language
- Address complications: dyspareunia, recurrent UTIs, obstetric risk, psychological trauma
- De-infibulation (opening of type III): can be offered antenatally or at any time
- Never perform re-infibulation after childbirth — illegal in most countries, harmful
- Mandatory reporting if child at risk — know local child safeguarding law in your GCC country
- Non-judgmental approach: victim, not perpetrator — many women had no choice
Sexual Health in Hajj & Umrah Pilgrims
Hajj (up to 3 million pilgrims annually) presents unique communicable disease considerations. Saudi MOH coordinates a comprehensive public health programme.
Communicable Disease Considerations
- Mandatory meningococcal ACWY vaccine for all Hajj pilgrims
- Recommended: influenza, pneumococcal, hepatitis B, polio vaccines
- Bloodborne pathogen risk: communal shaving of heads (razor injuries) — encourage disposable razors; consider HBV screening post-Hajj
- High-density congregation increases respiratory illness transmission (COVID, influenza, meningitis)
Reproductive Health for Hajj
- Many women suppress menstruation for Hajj (required for tawaf): norethisterone 5mg TDS from day 20 of cycle is commonly used and islamically permitted
- Counsel on breakthrough bleeding, contraindications (DVT history — prefer COCP if suitable)
- Provide usual contraception supply: women still need ongoing contraception during Hajj period
- Sexual activity is prohibited during ihram (state of ritual consecration) — relevant for health advice and counselling
Contraception for Expats in GCC
Access Considerations
- Most hormonal contraceptives require prescription — available from OB/GYN or GP in private hospitals
- Condoms widely available OTC in all GCC countries
- Emergency contraception available OTC in GCC pharmacies
- IUD/implant insertion available in most private hospitals — access may be limited in public sector for non-nationals
- Some pharmacists may be reluctant to dispense to unmarried women — advocate for your patient
Nursing Considerations for Expat Patients
- Ensure supply of contraception covers periods of travel/leave to home country
- Advise on storage in extreme heat (relevant in GCC climate): store at room temperature, away from direct sunlight
- Pill brands may differ from home country — check formulation equivalence
- LARC methods (implant, IUD) may be more practical for frequent travellers
- Ensure patient has prescription copy or medical letter for medications when travelling